Clinical Trials Logo

Clinical Trial Summary

Phase IV interventional study of adults (18 to 55) having a diagnosis of cystic fibrosis (mild, moderate or severe). The study is completely voluntary and is designed to measure participants use and the effectiveness of the device within the 510K indication of: airway clearance therapy when external manipulation of the thorax. The trial period shall be 21 days and include use of a FDA cleared pulse oximetry monitor (K131111), manual spirometer as well as completion of semi-weekly participant survey.


Clinical Trial Description

Phase IV interventional study, of participants with cystic fibrosis with mild, moderate or severe conditions, for the efficacy of the Electro Flo Percussor, Model 5000 (K031876), Regulation Number: 21 CFR 868.5665, with current FDA indication of: provide airway clearance therapy when external manipulation of the thorax is the physician's choice of treatment. Indications for this form of therapy are described by the American Association for Respiratory Care (AARC) in the Clinical Practices Guidelines for Postural Drainage Therapy ( I ) (1991). According to AARC guidelines, specific indications for external manipulation of the thorax include evidence or a suggestion of retained secretions, evidence that the patient is having difficulty with the secretion clearance, or presence of atelectasis caused by mucus plugging. In addition, the Med Systems Electro Flo Percussor Model 5000 is also indicated for external manipulation of the thorax to promote airway clearance or improve bronchial drainage for purposes of collecting mucus for diagnostic evaluation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03437811
Study type Observational
Source Mack Biotech, Corp.
Contact
Status Completed
Phase
Start date February 28, 2018
Completion date November 1, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05604495 - Screening for Cystic Fibrosis and Cystic Fibrosis Related Disorders in Chinese Adults With Bronchiectasis
Not yet recruiting NCT06339450 - Real World Environmental Exposure Study With Healthy and Cystic Fibrosis Subjects N/A
Active, not recruiting NCT06084468 - Cardiac Structure and Function in Patients With Cystic Fibrosis
Terminated NCT04375514 - Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis Phase 1